FDA’s Draft Agenda for the CFS/ME Patient Input Meeting
This article was originally published in RPM Report
Executive Summary
Here is a draft agenda made available by FDA ahead of the April 25-26 first-ever PDUFA V patient input workshop on chronic fatigue syndrome/myalgic encephalomyelitis. FDA notes that a final agenda will be made available a week before the meeting.